Product Wiki · Recalls · U.S. FDA — Device Enforcement

Recall Z-2210-2023 — RET Distal Probe. Used in Fluorescence in situ hybridization (FISH), a laboratory technique for detecting and locating a specific DNA sequence on a chromosome.

U.S. FDA — Device Enforcement · United Kingdom · 2023-05-24 · Class II

AI-assisted, human-edited — this page is drafted with AI from public-source data, then reviewed before publication. How we use AI →

Agency: U.S. FDA — Device Enforcement
Recall identifier: Z-2210-2023
Date of alert: 2023-05-24
Country / jurisdiction: United Kingdom
Risk level: Class II
Risk type: recall
Brand: Cytocell Ltd.
Product category: device
Product type: Devices
Barcode (EAN/GTIN): 05055844900516

Reported risk: DNAs used during the manufacture of two affected models were accidentally inverted during manufacturing.

Primary source: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.

Recall Z-2210-2023 — RET Distal Probe. Used in Fluorescence in situ hybridization (FISH), a laboratory technique for detecting and locating a specific DNA sequence on a chromosome.

Related